Citation Information :
Srinivas P, Subhose V, Sharma SK, Srinivas P, Babu G, Sharma OR, Narayanam S. Clinical Evaluation of Nisha Katakadi Kashaya and Yashada Bhasma in the Management of Type-2 Diabetes Mellitus (Madhumeha) : A Multicentre, Open Label Prospective Study. J Res Ayurvedic Sci 2018; 2 (2):108-121.
Introduction: Diabetes mellitus (DM) is a metabolic disorder characterized by abnormal carbohydrate, fat, and protein metabolism, which is clinically diagnosed based on hyperglycemia. Ayurveda has explained Avyayama (lack of exercise) as the first and foremost cause for diabetes.
Objectives: The main aim of the study was to assess the safety and clinical efficacy of Nisha Katakadi Kashaya and Yashada Bhasma (single as well as in combination) in the management of Type 2 Diabetes Mellitus.
Materials and Methods: This study was an interventional, randomized, openlabel multi-center clinical study. Total 193 subjects were treated with Nisha Katakadi Kashaya, 15 ml, Capsule Yashada Bhasma 125 mg individually in 1st and 2nd groups and Nisha Katakadi Kashaya, 15 ml and capsule. Yashada bhasma, 125 mg as a combination in the 3rd group. The duration of treatment was 12 weeks (84 days) in all the groups and the effect of the drug was assessed up to 14th week. Results: The effect of treatment was observed statistically highly significant (< 0.001) in relieving subjective parameters diabetes symptoms questionnaire (DSQ) score) and improving the quality of life of the subjects assessed by SF-36 (RAND) health survey score. But there is no change observed in parameters, i.e. HbA1c and Blood sugar levels.
Conclusion: Ayurveda treats Madhumeha in a broad concept which does not include just the hyperglycemia; the study provides good evidence in support of the efficacy and safety of the trial drugs individually and in combination in response to subjective parameters. It is also observed that, all the safety parameters like liver function test (LFT), kidney function test (KFT) and renal parameters also remain within normal limits.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes-estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May; 27(3):1047–1053.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes-estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(3):1047–1053.
Whiting Dr, Guariguata L, Weil C, Shawj. IDF Diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–321.]
Prof. K.R. Srikantha Murthy, Bhavaprakasa of Bhavamisra, Purvakhand Dvitiyabhaga, Section I, Part II, Chapter 7 (III), Krishnadas Academy, Varanasi - 2nd edition 2001-page 551.
Basavaraju NK. Meharoga nidanalaksanachikitsadyayah (9th Chapter). In: Basavarajeeyam. Hyderabad: Published by NIIHM; 2013. 328-331.
Vagbhata, Astanga Hrudaya, Nidanasthana, Atisaaragrahaniroga Nidana,8/30, edited by Pt. Hari Sadasiva Sastri Paradakara Bhisagacarya, Chaukhamba Sanskrit Sansthan, Varanasi, Reprint:2009, 497.
Madhava Nidanam, Madhavakara, translated by Dr. K. R. Srikantha Murthy, Chaukamba Oriental Publisher and Distributor, Varanasi; First Edition–1987, Chapter–33; no. 116.
Dr. Ram Nivas Sharam and Dr. Surendra sharama; Sahasrayogam, Chaukamba Sanskrit pratishtan, New Delhi, 2004, 21.
The Ayurvedic Formulary of India; Part-I, Department of Ayush, M/o Health and F.W., second edition - 2003; 239.
R. K. Sharama and Bhagavan Das; Charaka Samhita Vol- II; Nidanasthana, Chowkamaba Sanskrit series office, Varanasi, 1985; 54.
R.K.Sharama and Bhagavan Das; Charaka Samhita Vol-II; Nidanasthana, Chowkamaba Sanskrit series office, Varanasi, 1985; 65.
Babu S S. Endocrine Diseases and Medicines. In: The Principles and Practice of Kaya Chikitsa. Vol–III. Varanasi : Chaukamba Oriental Publisher and Distributor, Krishnadas Academy; 2007. 100-109.
Davidson's Principles and Practice of Medicine, Enghlish Language Book Society (ELBS), 14th Editino, 1985; Endocrine and Metabolic Diseases - Diabetes Mellitus; 462.
John E. Ware, Jr., Ph.D. with Kristin K. Snow, M.S. Mark Kosinski, M.A. Barbara Gandek, M. S. SF-36 Health Survey Manual and Interpretation Guide, The Health Institute, New England Medical Center Boston, Massachusetts @1993.
R.J.Marles and N. R. Farnsworth, “Antidiabetic plants and their active constituents,” Phytomedicine, Vol. 2, no. 2, pp. 137–189, 1995.
M. Habeck, “Diabetes treatments get sweet help from nature,” Nature Medicine, Vol. 9, no. 10, p. 1228, 2003.
J. Singh, E. Cumming, G. Manoharan, H. Kalasz, and E. Adeghate, “Medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions,” Open Medicinal Chemistry Journal, Vol. 5, supplement 2, pp. 70–77, 2011.
A. Y. Oubré, T. J. Carlson, S. R. King, and G. M. Reaven, “From plant to patient: an ethnomedical approach to the identification of new drugs for the treatment of NIDDM,” Diabetologia, vol. 40, no. 5, pp. 614–617, 1997.
Lad V. An introduction to Ayurveda. Altern Ther Health Med 1995;1: 57–63.
R.K.Sharama and Bhagavan Das; Charaka Samhita Vol-II; Nidanasthana, Chowkamaba Sanskrit series office, Varanasi, 1985; 55
Prof. K. R. Srikantha Murthy, Bhavaprakash of Bhavamishra, Chaukamba Oriental Publisher and Distributer, Varanasi, 2nd Edition (Reprint) 2002; Vol. II, 38 Chapter, page 484.
Chopra A, Doiphode V.V. Ayurvedic medicine; Core concept, therapeutic principles and current relevance. Med Clin North Am 2002; 86:75–89.
Cicero L. T. Chang, Yenshou Lin, Arlene P. Bartolome, Yi- Ching Chen, Shao-Chih Chiu, and Wen-Chin Yang “Herbal Therapies for Type 2 Diabetes Mellitus: Chemistry, Biology, and Potential Application of Selected Plants and Compounds” Evidence-Based Complementary and Alternative Medicine, Vol 2013 (2013).